tradingkey.logo

Zimmer Biomet Holdings Inc

ZBH
查看详细走势图
90.805USD
+0.275+0.30%
收盘 12/30, 16:00美东报价延迟15分钟
18.00B总市值
22.40市盈率 TTM

Zimmer Biomet Holdings Inc

90.805
+0.275+0.30%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.30%

5天

+1.54%

1月

-6.89%

6月

-0.44%

今年开始到现在

-14.03%

1年

-13.85%

查看详细走势图

TradingKey Zimmer Biomet Holdings Inc股票评分

单位: USD 更新时间: 2025-12-30

操作建议

Zimmer Biomet Holdings Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名36/207位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价103.16。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Zimmer Biomet Holdings Inc评分

相关信息

行业排名
36 / 207
全市场排名
108 / 4560
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 30 位分析师
持有
评级
103.158
目标均价
+11.22%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Zimmer Biomet Holdings Inc亮点

亮点风险
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
利润高增长
公司净利润处于行业前列,最新年度总收入7.68B美元
高分红
公司属于高分红公司,最新股息支付率21.51%
估值低估
公司最新PE估值22.40,处于3年历史低位
机构减仓
最新机构持股195.45M股,环比减少0.31%
布兰德斯投资公司持仓
明星投资者布兰德斯投资公司持仓,最新持仓市值15.49K

Zimmer Biomet Holdings Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Zimmer Biomet Holdings Inc简介

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
公司代码ZBH
公司Zimmer Biomet Holdings Inc
CEOTornos (Ivan)
网址https://www.zimmerbiomet.com/en

常见问题

Zimmer Biomet Holdings Inc(ZBH)的当前股价是多少?

Zimmer Biomet Holdings Inc(ZBH)的当前股价是 90.805。

Zimmer Biomet Holdings Inc的股票代码是什么?

Zimmer Biomet Holdings Inc的股票代码是ZBH。

Zimmer Biomet Holdings Inc股票的52周最高点是多少?

Zimmer Biomet Holdings Inc股票的52周最高点是114.440。

Zimmer Biomet Holdings Inc股票的52周最低点是多少?

Zimmer Biomet Holdings Inc股票的52周最低点是85.330。

Zimmer Biomet Holdings Inc的市值是多少?

Zimmer Biomet Holdings Inc的市值是18.00B。

Zimmer Biomet Holdings Inc的净利润是多少?

Zimmer Biomet Holdings Inc的净利润为903.80M。

现在Zimmer Biomet Holdings Inc(ZBH)的股票是买入、持有还是卖出?

根据分析师评级,Zimmer Biomet Holdings Inc(ZBH)的总体评级为持有,目标价格为103.158。

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是多少

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是4.053。
KeyAI